Acceleration of hyperfractionated chemoradiation regimen for advanced head and neck cancer

Head and Neck

Volumn 29, Issue 2, 2007, Pages 137-142

  Allen, Aaron M ^a,c   Elshaikh, Mohamed ^a   Worden, Francis P ^b   Bradford, Carol R ^b   Teknos, Theodores N ^b   Chepeha, Douglas B ^b   Tsien, Christina ^a   Dawson, Laura A ^a   Urba, Susan ^b   Wolf, Gregory T ^b   Normolle, Daniel ^a   Eisbruch, Avraham ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

Altered fractionation; Chemotherapy; Dysphagia; Head and neck cancer; Radiotherapy

Indexed keywords

CISPLATIN; FLUCONAZOLE; FLUOROURACIL; NARCOTIC AGENT; NYSTATIN;

ACUTE TOXICITY; ADULT; ADVANCED CANCER; AGED; ARTICLE; ASPIRATION PNEUMONIA; BONE NECROSIS; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CEREBROVASCULAR DISEASE; CLINICAL ARTICLE; CONTINUOUS INFUSION; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; DYSPHAGIA; ENTERIC FEEDING; ESOPHAGUS DISEASE; FATALITY; FEMALE; HEAD AND NECK CARCINOMA; HEARING LOSS; HUMAN; INOPERABLE CANCER; MALE; MUCOSA INFLAMMATION; NEUTROPENIA; NOSE OBSTRUCTION; PATIENT COMPLIANCE; PHARYNX DISEASE; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; SEPSIS; SIDE EFFECT; SKIN EXFOLIATION; SKIN NECROSIS; SQUAMOUS CELL CARCINOMA; TREATMENT FAILURE; TREATMENT OUTCOME; WEIGHT CHANGE;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BODY WEIGHT; CARCINOMA, SQUAMOUS CELL; CISPLATIN; DEGLUTITION DISORDERS; DOSE FRACTIONATION; ENTERAL NUTRITION; FEMALE; FLUOROURACIL; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; MUCOSITIS; RADIOTHERAPY DOSAGE; SKIN; TREATMENT OUTCOME; XEROSTOMIA;

EID: 33846543074     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.20495     Document Type: Article

References (25)

1. Brizel DM, Albers ME, Fisher SR, et al. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med 1998;338:1798-1804.
2. Adelstein DJ, Li Y, Adams GL, et al. An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol 2003;21:92-98.
3. Forastiere AA, Goepfert H, Maor M, et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 2003;349:2091-2098.
4. Fu KK, Pajak TF, Trotti A, et al. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys 2000;48:7-16.
5. Adelstein DJ, Saxton JP, Lavertu P, et al. Maximizing local control and organ preservation in stage IV squamous cell head and neck cancer with hyperfractionated radiation and concurrent chemotherapy. J Clin Oncol 2002;20:1405-1410.
6. Ang KK, Harris J, Garden AS, et al. Concomitant boost radiation plus concurrent cisplatin for advanced head and neck carcinomas: radiation therapy oncology group phase II trial 99-14. J Clin Oncol 2005;23:3008-3015.
7. Maguire PD, Meyerson MB, Neal CR, et al. Toxic cure: hyperfractionated radiotherapy with concurrent cisplatin and fluorouracil for stage III and IVA head-and-neck cancer in the community. Int J Radiat Oncol Biol Phys 2004;58:698-704.
8. Lee JH, Machtay M, Unger LD, et al. Prophylactic gastrostomy tubes in patients undergoing intensive irradiation for cancer of the head and neck. Arch Otolaryngol Head Neck Surg 1998;124:871-875.
9. Scolapio JS, Spangler PR, Romano MM, McLaughlin, MP, Salassa, JR. Prophylactic placement of gastrostomy feeding tubes before radiotherapy in patients with head and neck cancer: is it worthwhile? J Clin Gastroenterol 2001;33:215-217.
10. Beaver ME, Matheny KE, Roberts DB, Myers JN. Predictors of weight loss during radiation therapy. Otolaryngol Head Neck Surg 2001;125:645-648.
11. Overgaard J, Hansen HS, Specht L, et al. Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial. Lancet 2003;362:933-940.
12. Kalbfleish JPR. The statistical analysis of failure time data. New York: Wiley; 1980.
13. de Wet M, Falkson G, Rapoport BL. Small cell lung cancer: analysis of factors influencing the response to treatment and survival. Oncology 1994;51:523-534.
14. Feinstein AR, Wells CK. A clinical-severity staging system for patients with lung cancer. Medicine (Baltimore) 1990;69:1-33.
15. Brookes GB. Nutritional status-a prognostic indicator in head and neck cancer. Otolaryngol Head Neck Surg 1985;93:69-74.
16. Lin A, Jabbari S, Worden FP, Dawson LA, Ship JA, Eisbruch A. Metabolic abnormalities associated with weight loss during chemoirradiation of head-and-neck cancer. Int J Radiat Oncol Biol Phys 2005;63:1413-1418.
17. Tyldesley S, Sheehan F, Munk P, et al. The use of radiologically placed gastrostomy tubes in head and neck cancer patients receiving radiotherapy. Int J Radiat Oncol Biol Phys 1996;36:1205-1209.
18. Mekhail TM, Adelstein DJ, Rybicki LA, Larto MA, Saxton JP, Lavertu P Enteral nutrition during the treatment of head and neck carcinoma: is a percutaneous endoscopic gastrostomy tube preferable to a nasogastric tube? Cancer 2001;91:1785-1790.
19. Al-Otman M, Amdur R, Morris C, et al. Does feeding tube placement predict for long-term swallowing disability after radiotherapy for head and neck cancer? Head Neck 2003;25:741-747.
20. Suntharalingam M, Haas ML, Van Echo DA, et al. Predictors of response and survival after concurrent chemotherapy and radiation for locally advanced squamous cell carcinomas of the head and neck. Cancer 2001;91:548-554.
21. Herrmann T, Jakubek A, Trott KR. The importance of the timing of a gap in radiotherapy of squamous cell carcinomas of the head and neck. Strahlenther Onkol 1994;170:545-549.
22. Lee WT, Akst LM, Adelstein DL, et al. Risk factors for hypopharyngeal/upper esophageal strictures formation after concurrent chemoradiation, in Proceedings of the 6th International Conference on Head and Neck Cancer, Washington DC, August 7-11, 2004:s090.
23. Laurell G, Kraepelien T, Mavroidis P, et al. Stricture of the proximal esophagus in head and neck carcinoma patients after radiotherapy. Cancer 2003;97:1693-1700.
24. Haddad R, Wirth L, Costello R, Weeks L, Posner M. Phase II randomized study of concomitant chemoradiation using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with newly diagnosed locally advanced squamous cell carcinoma of the head and neck. Semin Oncol 2003;30:84-88.
25. Eisbruch A, Schwartz M, Rasch C, et al. Dysphagia and aspiration after chemoradiotherapy for head-and-neck cancer: which anatomic structures are affected and can they be spared by IMRT? Int J Radiat Oncol Biol Phys 2004;60:1425-1439.